Baird Financial Group
PETS icon

Baird Financial Group’s PetMed Express PETS Stock Holding History

Baird Financial Group’s Portfolio PETS Stock Details PETS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-68,613
Closed -$1.21M – 1739
2022
Q4 		$1.21M Sell
68,613
-655
-0.9% -$13K ﹤0.01% 1013
2022
Q3 		$1.35M Buy
69,268
+349
+0.5% +$7.41K ﹤0.01% 959
2022
Q2 		$1.37M Sell
68,919
-1,214
-2% -$27.1K ﹤0.01% 975
2022
Q1 		$1.81M Buy
70,133
+1,367
+2% +$35.5K ﹤0.01% 942
2021
Q4 		$1.74M Buy
68,766
+4,649
+7% +$129K ﹤0.01% 991
2021
Q3 		$1.72M Buy
64,117
+31,993
+100% +$921K ﹤0.01% 995
2021
Q2 		$1.02M Sell
32,124
-2,391
-7% -$75.9K ﹤0.01% 1168
2021
Q1 		$1.21M Sell
34,515
-38,205
-53% -$1.33M ﹤0.01% 1053
2020
Q4 		$2.33M Buy
72,720
+3,892
+6% +$120K 0.01% 752
2020
Q3 		$2.18M Buy
68,828
+700
+1% +$23.2K 0.01% 717
2020
Q2 		$2.43M Buy
68,128
+225
+0.3% +$7.81K 0.01% 674
2020
Q1 		$1.95M Sell
67,903
-1,985
-3% -$52K 0.01% 694
2019
Q4 		$1.64M Buy
69,888
+490
+0.7% +$11K 0.01% 835
2019
Q3 		$1.25M Buy
69,398
+1,004
+1% +$16.6K ﹤0.01% 915
2019
Q2 		$1.07M Buy
68,394
+31,274
+84% +$615K ﹤0.01% 960
2019
Q1 		$846K Buy
37,120
+5,215
+16% +$118K ﹤0.01% 908
2018
Q4 		$742K Buy
31,905
+16,729
+110% +$447K 0.01% 887
2018
Q3 		$496K Buy
15,176
+1
+0% +$37 ﹤0.01% 1048
2018
Q2 		$668K Sell
15,175
-1
-0% -$39 ﹤0.01% 934
2018
Q1 		$634K Sell
15,176
-1,836
-11% -$84.8K ﹤0.01% 946
2017
Q4 		$774K Sell
17,012
-1,326
-7% -$52.2K 0.01% 890
2017
Q3 		$608K Buy
18,338
+1,478
+9% +$60.2K ﹤0.01% 936
2017
Q2 		$685K Sell
16,860
-4,715
-22% -$146K 0.01% 879
2017
Q1 		$435K Buy
21,575
+3,175
+17% +$67.2K ﹤0.01% 987
2016
Q4 		$424K Hold
18,400
– – ﹤0.01% 965
2016
Q3 		$373K Hold
18,400
– – ﹤0.01% 1004
2016
Q2 		$345K Buy
+18,400
New +$338K ﹤0.01% 1014

Other funds holding PETS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Baird Financial Group's PETS Position: Q1 2023 in Review

Baird Financial Group sold out of PetMed Express (PETS) in Q1 2023, closing a stake of 68,613 shares — an estimated $1.21M sold.

Baird Financial Group first reported a position in PETS in Q2 2016 and held it in 27 quarters. The position peaked at $2.43M in Q2 2020. 165 funds tracked by Wall St. Rank hold PETS as of Q1 2023.

  • Baird Financial Group reported no remaining PetMed Express position as of Q1 2023 after selling out during the quarter.
  • Baird Financial Group sold 68,613 PetMed Express shares in Q1 2023, an estimated $1.21M.
  • Baird Financial Group first reported a position in PetMed Express in Q2 2016 and held it in 27 quarters.
  • Baird Financial Group's PetMed Express position peaked at $2.43M in Q2 2020.
  • 165 funds tracked by Wall St. Rank held PetMed Express as of Q1 2023.

Based on Baird Financial Group's 13F filing for Q1 2023, filed 15 May 2023.